General MedicationsINJECTIONStandard
ADENOSINE
ADENOSINE
Standard Dose
3MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ADENOSINE is listed in Drugs@FDA under application 206778 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ADENOSINE Form and strength INJECTABLE;INJECTION - 3MG/ML Sponsor GLAND Submission history Latest submission status date: 2018-02-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview ADENOSINE is listed in Drugs@FDA under application 206778 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ADENOSINE Form and strength INJECTABLE;INJECTION - 3MG/ML Sponsor GLAND Submission history Latest submission status date: 2018-02-16 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.